The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2026

Filed:

Oct. 14, 2021
Applicants:

Institut Du Cerveau ET DE LA Moelle Epiniere, Paris, FR;

Institut National DE LA Santé ET DE LA Recherche Médicale, Paris, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Assistance Publique—hôpitaux DE Paris, Paris, FR;

Sorbonne Universite, Paris, FR;

Universite Paris-saclay, Gif-sur-Yvette, FR;

Inventors:

Bruno Figadere, Saint Cheron, FR;

Rita Raisman-Vozari, Paris, FR;

Patrick Pierre Michel, Paris, FR;

Laurent Ferrie, Palaiseau, FR;

Clémence Rose, Beziers, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/65 (2006.01); A61P 25/28 (2006.01); C07C 231/12 (2006.01); C07C 235/84 (2006.01);
U.S. Cl.
CPC ...
A61K 31/65 (2013.01); A61P 25/28 (2018.01); C07C 231/12 (2013.01); C07C 235/84 (2013.01); C07C 2603/46 (2017.05);
Abstract

The present invention relates to the field of medicine. In particular, it relates to the use of tetracycline derivatives in the treatment or prevention of a neurodegenerative or neuroinflammatory disease, such as Parkinson's disease.


Find Patent Forward Citations

Figadere, Bruno. (2026). Tetracycline derivatives for treating neurodegenerative or neuroinflammatory diseases (U.S. Patent No. 12746247). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12746247

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…